Important Update: PHBI Is Technically Triggering A Potential Pre-Market Breakout According To Quotestream...

January 23rd, 2020 Hello Member, Quick update... PHBI is technically triggering a potential breakout according to level 2 Quotestream. Pharmagreen Biotech, Inc. just released very exciting news January 16th, 2020 signaling their 63,000sf. complex is getting closer to completion, which translates into potential revenue. Pharmagreen Biotech Inc. (PHBI) is my #1 stock for this exact sector. Biotech companies are looking to capitalize on the anticipated growth of the cannabis-derived pharmaceutical market by levering the mounting data on the therapeutic effects of cannabis and deploying rigorous testing for quality, safety, and efficacy. Cannabinoid research, historically led by scientists in Israel, has garnered much interest in the U.S. over the past five years. Breaking News Pharmagreen Biotech Inc. Releases Huge News Regarding Their 63,000sf Complex! Pharmagreen Selects ICF (Insulated Concrete Forms) Building Technology for the Construction of its Cannabis Biotech Complex Building Material CARSON CITY, NV, Jan. 16, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Pharmagreen Biotech, Inc., (OTC: PHBI), is pleased to announce today that it signed a memorandum of understanding with Here to Serve Holding Corp., (OTC:HTSC) to provide consulting services and supply ICF building material (Insulated Concrete Forms) for the construction of Pharmagreen’s 63,000 square foot facility, the Cannabis Biotech Complex. The complex, which will take about 18 months to construct, makes use of cutting edge technologies in its engineering, water recycling and conservation techniques, as well as with its construction material resulting in a reduced carbon footprint and secure, uniquely advanced, eco-friendly and semi-automated tissue culture, clean-room laboratory, extraction, distillation and research facility. We project that this premier cannabis biotech complex will provide for the annual in-vitro production and supply of over 10 million cannabis tissue cultured plantlets and ready-to-grow starter crops for licensed commercial grow operations, micro-cultivators as well as orchard style high CBD hemp farms with its on field successfully grown proprietary CBD Dana hemp strain. This is the type of news that has the potential to send shares flying over the long term. In my opinion PHBI is positioned very well to lead the field. Growing adoption of cannabis as a pharmaceutical product for treating severe medical conditions, such as cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and other neurological conditions is anticipated to drive the demand for medical application sky high. Increasing need for pain management therapies and growing disease burden of chronic pain among elders is also expected to boost demand. Pharmagreen Biotech ([PHBI](. Pharmagreen raising the bar in the cannabis space, both in the quality of cannabis produced and the efficiency of the growing method. The company is highly focused on the rapidly evolving CBD industry by developing supply chains for CBD hemp growers utilizing the CBD Dana hemp strain. Pharmagreen's model is to provide the hemp farmers the highest quality starter female plantlets to produce the highest quality biomass for the production of CBD formulations for human and animal use.  Pharmagreen's ability to supply high CBD starter plantlets paired with high level of expertise in farming the strain provides a very lucrative high CBD hemp farming opportunity for the farmers by making highly efficient use of land.  For example, greater profits and higher yields can be generated from 10 acres with Pharmagreen's high CBD strain and farming techniques than from farming 1,000 acres using standard industrial hemp from seed. The end product using Pharmagreen's CBD strain and farming techniques ultimately provides the highest quality, medical grade, flower tops biomass. Pharmagreen’s proprietary method generates harvest yields a HUNDRED times better than standard industrial hemp from seed. Multiply that by the current spot price for a kilo of CBD product and consider the market opportunity. Pharmagreen's mission is to advance the technology of cannabis tissue culture science and to provide the highest quality, 100% germ free, disease free and all genetically identical plantlets of cannabis and other flora while offering full spectrum DNA testing for plant identification, live genetics preservation using low temperature storage for various cannabis and horticulture plants; extraction of botanical oils, mainly CBD oil, and to deliver laboratory based services to the North American Cannabis and agriculture sectors.  8 Enormous Catalysts Pharmagreen Is Focused On - The Cannabis/Botany Biotech Centre will employ between 80-100 persons on site.       - This pioneering micro-propagation technology developed by B.R.I.M. allows for large-scale production. - Application of this industry-leading botanical tissue culture technology may also be adapted for any plant species. - Cold storage capacity will provide for long term plant tissue sample preservation and banking of specific live plantlet strains for future research and production. - Energy efficient and state-of-the-art greenhouse space will further allow for year-round nurseries safeguarding cultured and developing plants for all growing seasons. - B.R.I.M. has developed a proprietary industrial hemp strain named “CBD DANA” which contains a high cannabidiol content of 10-20%, less than 0.3% THC and a unique profile of active terpene and alkamide entourage constituents. - Onsite research and development will continue to enhance existing micro-propagation techniques for cultured plantlets and help refine developing protocols for a variety of Cannabis strains for indoor and outdoor cannabis growers. - The Cannabis/Botany Biotech Centre will provide analytic services, genomic characterization and testing of botanical material for industry certification and also include commercial-scale plant distillation and extraction capacity for producing botanical oils and other active medicinal constituents.     5 Services Pharmagreen Offers To Dominate The Market! The Pharmagreen Botany Centre is dedicated to breaking boundaries to become the most internationally recognized and valued biotech science solutions company in North America for its proprietary micro-propagation techniques, tissue culture plantlets production, research and development for plants sustainability, preservation of genetics, extraction of botanical oils, Cannabis products development and plant DNA species identification and certification centre. Plant Tissue Culture Unit CHIBAFREEN™ a new, highly evolved, state-of-the art in vitro plant production method is introduced by the company Botanical Research In Motion Inc. (B.R.I.M.) for exclusive use by WFS Pharmagreen Inc. for various kinds of high quality transplant production in the company’s Botany Center.  This proprietary process was developed by Dr. Fawzia Afreen. In this method relatively small chlorophyllous (leafy) explants or single nodal cuttings are grown inside the culture vessel under pathogen free, sterile condition under artificial light.  The conventional in vitro system for transplant production involves four stages: 1) Initiation, 2) Multiplication, 3) Rooting and 4) Hardening. In our new method one of the stages is eliminated, which reduce the production period and costs drastically. The root formation and the hardening of the plant are carried out using our new technology, coined as Chibafreen™ in vitro plant production. The Cannabis Botany Center will produce approximately 10 million plantlets at full capacity. DNA Testing Services Unit  Using DNA testing, growers can ensure they have the right genetics of plants to grow, and protect their crops from uncertified plant species. No other DNA commercial facility is in operation west of Manitoba. Saskatchewan Research Council (SRC’s ) Biotechnology Laboratories exists for scientific purposes only. B.R.I.M. will use SSR marker (Simple sequence repeat) technology to fingerprint varieties. We will develop an extensive database for several crops. Clients/growers simply need to collect leaf samples (300 – 500 g) of a suspect variety and our lab will compare its SSR fingerprint to varieties in our database. These services will be provided by B.R.I.M. as a value-added service for Pharmagreen’s Botany Center. Cold Storage Unit Lowering temperature can slow the metabolic processes (e.g. respiration) and prevent undesirable loss of dry mass and associated deteriorations of quality. The proper combination of air temperature, light intensity and propriety techniques during storage would contribute to minimizing increase/decrease in dry weight and preserving photosynthetic ability and provide immediate regrowth of plantlets after storage.  First of its kind service for: To preserve clients plants strains and propagate them when necessary. * To maintain a variety of plants species indefinitely with the immediate ability for mass reproduction. * Flexible production schedule on a commercial scale is possible. Nursery Unit Year-round greenhouse structures will be built on the property to provide nursery service for cannabis plants inclusive of indica, sativa and hemp strains for the cannabis cultivators. The company will be working closely with industrial hemp farmers for the production of hemp strains with high CBD content. B.R.I.M. Inc. has completed successful research on its high CBD strain dubbed “CBD DANA” which content is well over 10% in CBD and the THC at below .03% which makes it ideal for industrial hemp farming. “CBD DANA” will be available for sale exclusively through Pharmagreen’s Cannabis Botany Center. Extraction Unit Extraction service for cannabis plant oils will be provided for all clients as well as for future production of Pharmagreen brands of cannabis products for human use. Additionally, B.R.I.M. will be conducting research and development of cannabis formulations for Pharmagreen brands. The extraction and distillation equipment will be certified medical grade equipment with a capacity for commercial scale production 6 Strategic Partners Aligned With Pharmagreen About Signify (Formerly Philips Lighting) Signify (Euronext: LIGHT) is the world leader in lighting for professionals and consumers and lighting for the Internet of Things. Their Philips products, Interact connected lighting systems and data-enabled services, deliver business value and transform life in homes, buildings and public spaces. With 2018 sales of EUR 6.4 billion, they have approximately 29,000 employees and are present in over 70 countries. They unlock the extraordinary potential of light for brighter lives and a better world. They have been named Industry Leader in the Dow Jones Sustainability Index for two years in a row. News from Signify is located at the Newsroom, Twitter and LinkedIn. Alliance Growers Corp., a Canadian publicly-traded company (Symbol: ACG on the CSE), is a cannabis company dedicated to building shareholder value through its focus on the cannabis sector with an eye toward regulated medical infrastructure within regional, national and international markets. Through their ‘Four Pillars’ business strategy they have mapped out a strategy that seeks to create networks between cannabis growers, cannabidiol (CBD) oil extractors, and new agricultural technologies. One of Alliance Growers’ primary goals is the development of a Cannabis Botany Centre with BC New Co. as a strategic equity investor with Pharmagreen. Alliance Growers and its partners will jointly develop and operate multiple cannabis-focused botany centres across Canada. These cannabis botany centres’ will primarily produce tissue cultured plantlets for sale and distribution to licensed cultivators and the retail market. Alliance Growers is focused on securing long-term plantlet supply contracts and off take agreements at wholesale cost for flower to be used in CBD oil extraction. This will be accomplished through a series of strategic joint ventures with licensed producers. Development of land for the growth of high quality cannabis plants would occur in an offshore, low operating cost jurisdictions where it is anticipated that the majority of the plant production would be processed for the extraction of pharmaceutical grade CBD Oil. The company was incorporated in 2014 and has its head office in Vancouver, Canada. Alliance Growers is publicly traded on the Canadian Stock Exchange under the symbol ACG and on the Frankfurt Stock exchange under the symbol 1LA. B.R.I.M. is a privately held research and development company focused on the cannabis industry. Developer of “Chibafreen” invitro plant micro propagation proprietary technology for the production of tissue cultures for exclusive use in the Pharmagreen’s Cannabis Botany Center. The company has also been developing for the last three years tissue culture protocols for variety of cannabis strains. In particular it has developed a hemp strain with a high CBD, very low THC content dubbed as “CBD Dana” for the medical cannabis market and industrial scale hemp production. Pharmagreen’s Cannabis Botany Center is the exclusive supplier of “CBD Dana” plantlets. Future research and development will be for the cannabis oils extracts formulations for humans to be produced and branded by Pharmagreen. B.R.I.M. will use SSR marker (Simple sequence repeat) technology to fingerprint varieties. We will develop an extensive database for several crops. These services will provided by B.R.I.M. as a value added service for Pharmagreen’s Botany Center. The company is currently in application process with Health Canada for the Dealer Licence. Cannabis Compliance Inc. As Canada’s original cannabis consulting firm, their number one objective is to obtain Health Canada approval for their clients. Canada is the only G7 country to legalize both medical and recreational cannabis on a national level. To facilitate this, Canada has established the most stringent requirements for commercial production on the planet. Achieving compliance means following strict protocols regarding security system designs and procedures, quality assurance programs, record keeping, sanitation and standard operating procedures. Gary Fields Architecture is a full service firm established on the owner’s platform of experience in architecture, planning, urban design, environment, and construction. PHBI provides project leadership from pre-project to the end of construction with a single point of responsibility for performance of a design and construction project. The firm works on projects of all scales with private owners, commercial clients and major institutional clients. The Green Light team has over two decades of experience creating, funding, and bringing technology innovations to market.  They are a group of entrepreneurs that understand the challenges companies face developing, funding, and building teams that can execute their business plans. Their team is comprised of founders and senior management of public and private companies. They have raised over $30 million for various initiatives. They are now offering that expertise to our clients in the form of three core services: SR&ED is the Scientific Research and Experimental Development (SR&ED) tax incentive program, which encourages Canadian businesses to conduct research and development (R&D) in Canada. Green Light’s vision of SR&ED is of a multi-year funding vehicle. As such, we strive to become long-term, trusted partners with our clients. Don’t get us confused with consultants, who tend to be contractors for hire with a short-term, task-oriented focus. We look for partnership opportunities to take your business to the next level. We often start working with new clients using our SR&ED service. As the relationship develops, many clients also take advantage of our assistance, in growing their business, by utilizing our knowledge, technical expertise, or our ability to raise capital. For more information please visit www.greenlightip.com Don't let PHBI slip by you... Sincerely, Fierce Analyst | Jaks Swift Editorial Writer     I am not a licensed financial adviser. All potential percentage gains are based on from the low to the high of day. Fierce full disclosure is to be read and fully understood before using Fierce's website, or joining Fierce's email or text list. By viewing Fierce's website and/or reading Fierce's email or text newsletter you are agreeing to -> [(   Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. A member of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com ("SCF") and an interest in the limited liability company that owns and operates fierce investor . com ("FI"). From time to time, non-affiliated third parties hire Stock Wire News, SCF and/or FI jointly to publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between Fierce Investor (FI) and StockWireNews LLC, (a non affiliated 3rd party), FI has been hired for a period beginning on 10/14/19 and ending on 10/15/19 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid ten thousand USD via ACH. We own zero shares of (PHBI). A member of StockWireNews LLC owns an interest in Fierce Investor. Pursuant to an agreement between StockWireNews LLC and Awareness Consulting Network LLC (a non affiliated 3rd party), StockWireNews has been hired for a period beginning on 10/14/19 and ending on 10/15/19 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid thirty thousand USD via bank wire transfer. We own zero shares of (PHBI). Pursuant to an agreement between Fierce Investor (FI) and StockWireNews LLC, (a non affiliated 3rd party), FI has been hired for a period beginning on 12/13/19 and ending on 12/16/19 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid ten thousand USD via ACH. We own zero shares of (PHBI). A member of StockWireNews LLC owns an interest in Fierce Investor. Pursuant to an agreement between StockWireNews LLC and Awareness Consulting Network LLC (a non affiliated 3rd party), StockWireNews has been hired for a period beginning on 12/13/19 and ending on 12/16/19 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid thirty thousand USD via bank wire transfer. We own zero shares of (PHBI). Pursuant to an agreement between Fierce Investor (FI) and StockWireNews LLC, (a non affiliated 3rd party), FI has been hired for a period beginning on 1/22/20 and ending on 1/23/20 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid five thousand and fifty USD via ACH. We own zero shares of (PHBI). To date, we have been compensated a total of thirty thousand and fifty USD via ACH to disseminate information about (PHBI). A member of StockWireNews LLC owns an interest in Fierce Investor. Pursuant to an agreement between StockWireNews LLC and Awareness Consulting Network LLC (a non affiliated 3rd party), StockWireNews has been hired for a period beginning on 1/22/20 and ending on 1/23/20 to publicly disseminate information about (PHBI) via Website, Email and SMS. We have been paid thirty-five thousand USD via bank wire transfer. We own zero shares of (PHBI). To date, we have been compensated a total of ninety-five thousand USD via bank wire transfer to disseminate information about (PHBI).    Fierce Investor | 539 W Commerce St, Dallas, TX 75208 [Unsubscribe {EMAIL}]( [Update Profile]( | [About Constant Contact]( Sent by jax@fierceanalyst.net